[144] AnaptysBio, Inc. SEC Filing
AnaptysBio, Inc. (ANAB) Form 144 shows an intended sale of 10,231 common shares with an aggregate market value of $200,712.78 to be executed on or about 08/08/2025 through Morgan Stanley Smith Barney on NASDAQ. The filing states these shares were acquired by a stock option exercise on 08/08/2025 with payment in cash. The notice also discloses prior sales by the same person, HOLLINGS C RENTON: 20,925 shares sold 07/02/2025 for $493,189.70 and 3,015 shares sold 06/18/2025 for $72,269.55. The signer represents there is no undisclosed material adverse information.
AnaptysBio, Inc. (ANAB) Il Form 144 indica l'intenzione di vendere 10,231 azioni ordinarie per un valore di mercato aggregato di $200,712.78, da eseguire il 08/08/2025 circa tramite Morgan Stanley Smith Barney sul NASDAQ. Il deposito dichiara che queste azioni sono state acquisite mediante esercizio di un'opzione su azioni il 08/08/2025 con pagamento in contanti. L'avviso evidenzia inoltre vendite precedenti della stessa persona, HOLLINGS C RENTON: 20,925 azioni vendute il 07/02/2025 per $493,189.70 e 3,015 azioni vendute il 06/18/2025 per $72,269.55. Il firmatario dichiara che non esistono informazioni negative materiali non divulgate.
AnaptysBio, Inc. (ANAB) El Formulario 144 muestra la intenci贸n de vender 10,231 acciones ordinarias por un valor de mercado agregado de $200,712.78, que se ejecutar铆a en o alrededor del 08/08/2025 a trav茅s de Morgan Stanley Smith Barney en NASDAQ. El registro indica que estas acciones fueron adquiridas mediante el ejercicio de una opci贸n sobre acciones el 08/08/2025 con pago en efectivo. El aviso tambi茅n revela ventas previas de la misma persona, HOLLINGS C RENTON: 20,925 acciones vendidas el 07/02/2025 por $493,189.70 y 3,015 acciones vendidas el 06/18/2025 por $72,269.55. El firmante declara que no existe informaci贸n adversa material no divulgada.
AnaptysBio, Inc. (ANAB)鞚� Form 144 氍胳劀鞐愲姅 10,231欤� 氤错喌欤茧ゼ 齑� 鞁滌灔 臧�旃� $200,712.78搿� 毵る弰頃� 鞓堨爼鞚措┌, 08/08/2025瓴� Morgan Stanley Smith Barney毳� 韱淀暣 NASDAQ鞐愳劀 鞁ろ枆霅� 鞓堨爼鞚措澕瓿� 旮办灛霅橃柎 鞛堨姷雼堧嫟. 鞁犼碃靹滌棎電� 鞚� 欤检嫕霌れ澊 08/08/2025鞐� 欤检嫕毵れ垬鞓奠厴 頄夓偓搿� 順勱笀 瓴办牅頃橃棳 旆摑霅橃棃雼り碃 氇呾嫓霅橃柎 鞛堨姷雼堧嫟. 韱奠靹滌棎電� 臧欖潃 靷瀸鞚� HOLLINGS C RENTON鞚� 鞚挫爠 毵る弰 雮挫棴霃� 瓿店皽霅橃柎 鞛堨姷雼堧嫟: 20,925欤茧ゼ 07/02/2025鞐� $493,189.70鞐� 毵る弰, 3,015欤茧ゼ 06/18/2025鞐� $72,269.55鞐� 毵る弰頄堨姷雼堧嫟. 靹滊獏鞛愲姅 瓿店皽霅橃 鞎婌潃 欷戨寑頃� 攵堧Μ頃� 鞝曤炒臧� 鞐嗢潓鞚� 歆勳垹頃╇媹雼�.
AnaptysBio, Inc. (ANAB) Le formulaire 144 indique l'intention de vendre 10,231 actions ordinaires pour une valeur de march茅 totale de $200,712.78, op茅ration devant 锚tre effectu茅e vers le 08/08/2025 via Morgan Stanley Smith Barney sur le NASDAQ. Le d茅p么t pr茅cise que ces actions ont 茅t茅 acquises par exercice d'une option sur actions le 08/08/2025 avec paiement en esp猫ces. L'avis divulgue 茅galement des ventes ant茅rieures par la m锚me personne, HOLLINGS C RENTON : 20,925 actions vendues le 07/02/2025 pour $493,189.70 et 3,015 actions vendues le 06/18/2025 pour $72,269.55. Le signataire d茅clare qu'il n'existe aucune information d茅favorable mat茅rielle non divulgu茅e.
AnaptysBio, Inc. (ANAB) Das Formular 144 weist den beabsichtigten Verkauf von 10,231 Stammaktien mit einem Gesamtmarktwert von $200,712.78 aus, der am oder um den 08/08/2025 眉ber Morgan Stanley Smith Barney an der NASDAQ ausgef眉hrt werden soll. Die Einreichung gibt an, dass diese Aktien am 08/08/2025 durch Aus眉bung einer Aktienoption mit Barzahlung erworben wurden. Die Mitteilung offenbart zudem fr眉here Verk盲ufe derselben Person, HOLLINGS C RENTON: 20,925 Aktien verkauft am 07/02/2025 f眉r $493,189.70 und 3,015 Aktien verkauft am 06/18/2025 f眉r $72,269.55. Der Unterzeichner erkl盲rt, dass keine nicht offengelegten wesentlichen nachteiligen Informationen vorliegen.
- Form 144 filed and details disclosed, including broker, sale date, and aggregate market value, demonstrating regulatory compliance.
- Securities were acquired via stock option exercise with cash payment as explicitly stated in the filing.
- Insider selling reported: HOLLINGS C RENTON sold 20,925 shares on 07/02/2025 for $493,189.70 and 3,015 shares on 06/18/2025 for $72,269.55.
- Planned sale of 10,231 shares valued at $200,712.78 is scheduled for 08/08/2025, indicating continued insider monetization.
Insights
TL;DR Insider exercised options and plans a modest sale; filing details are disclosed and likely immaterial to capitalization.
The filing documents a stock option exercise that created 10,231 shares, immediately slated for sale via Morgan Stanley Smith Barney on NASDAQ for $200,712.78. Given the reported shares outstanding of 27,996,963, the planned sale represents a very small fraction of total capitalization (approximately 0.037%). The filing also lists two recent sales by the same person on 07/02/2025 and 06/18/2025, showing prior monetization activity. For investors, the item is transparent but not likely market-moving based on size alone.
TL;DR Proper Form 144 disclosure and a signed representation reduce regulatory risk; multiple sales by the same individual warrant attention.
The notice includes required disclosures: acquisition method (stock option exercise), payment method (cash), broker (Morgan Stanley Smith Barney) and an affirmation that no material nonpublic information is known. The form also records recent sales by HOLLINGS C RENTON on 07/02/2025 and 06/18/2025. From a compliance standpoint, the filing appears complete; governance review would note repeated insider sales but the absolute sizes disclosed are modest relative to total shares outstanding.
AnaptysBio, Inc. (ANAB) Il Form 144 indica l'intenzione di vendere 10,231 azioni ordinarie per un valore di mercato aggregato di $200,712.78, da eseguire il 08/08/2025 circa tramite Morgan Stanley Smith Barney sul NASDAQ. Il deposito dichiara che queste azioni sono state acquisite mediante esercizio di un'opzione su azioni il 08/08/2025 con pagamento in contanti. L'avviso evidenzia inoltre vendite precedenti della stessa persona, HOLLINGS C RENTON: 20,925 azioni vendute il 07/02/2025 per $493,189.70 e 3,015 azioni vendute il 06/18/2025 per $72,269.55. Il firmatario dichiara che non esistono informazioni negative materiali non divulgate.
AnaptysBio, Inc. (ANAB) El Formulario 144 muestra la intenci贸n de vender 10,231 acciones ordinarias por un valor de mercado agregado de $200,712.78, que se ejecutar铆a en o alrededor del 08/08/2025 a trav茅s de Morgan Stanley Smith Barney en NASDAQ. El registro indica que estas acciones fueron adquiridas mediante el ejercicio de una opci贸n sobre acciones el 08/08/2025 con pago en efectivo. El aviso tambi茅n revela ventas previas de la misma persona, HOLLINGS C RENTON: 20,925 acciones vendidas el 07/02/2025 por $493,189.70 y 3,015 acciones vendidas el 06/18/2025 por $72,269.55. El firmante declara que no existe informaci贸n adversa material no divulgada.
AnaptysBio, Inc. (ANAB)鞚� Form 144 氍胳劀鞐愲姅 10,231欤� 氤错喌欤茧ゼ 齑� 鞁滌灔 臧�旃� $200,712.78搿� 毵る弰頃� 鞓堨爼鞚措┌, 08/08/2025瓴� Morgan Stanley Smith Barney毳� 韱淀暣 NASDAQ鞐愳劀 鞁ろ枆霅� 鞓堨爼鞚措澕瓿� 旮办灛霅橃柎 鞛堨姷雼堧嫟. 鞁犼碃靹滌棎電� 鞚� 欤检嫕霌れ澊 08/08/2025鞐� 欤检嫕毵れ垬鞓奠厴 頄夓偓搿� 順勱笀 瓴办牅頃橃棳 旆摑霅橃棃雼り碃 氇呾嫓霅橃柎 鞛堨姷雼堧嫟. 韱奠靹滌棎電� 臧欖潃 靷瀸鞚� HOLLINGS C RENTON鞚� 鞚挫爠 毵る弰 雮挫棴霃� 瓿店皽霅橃柎 鞛堨姷雼堧嫟: 20,925欤茧ゼ 07/02/2025鞐� $493,189.70鞐� 毵る弰, 3,015欤茧ゼ 06/18/2025鞐� $72,269.55鞐� 毵る弰頄堨姷雼堧嫟. 靹滊獏鞛愲姅 瓿店皽霅橃 鞎婌潃 欷戨寑頃� 攵堧Μ頃� 鞝曤炒臧� 鞐嗢潓鞚� 歆勳垹頃╇媹雼�.
AnaptysBio, Inc. (ANAB) Le formulaire 144 indique l'intention de vendre 10,231 actions ordinaires pour une valeur de march茅 totale de $200,712.78, op茅ration devant 锚tre effectu茅e vers le 08/08/2025 via Morgan Stanley Smith Barney sur le NASDAQ. Le d茅p么t pr茅cise que ces actions ont 茅t茅 acquises par exercice d'une option sur actions le 08/08/2025 avec paiement en esp猫ces. L'avis divulgue 茅galement des ventes ant茅rieures par la m锚me personne, HOLLINGS C RENTON : 20,925 actions vendues le 07/02/2025 pour $493,189.70 et 3,015 actions vendues le 06/18/2025 pour $72,269.55. Le signataire d茅clare qu'il n'existe aucune information d茅favorable mat茅rielle non divulgu茅e.
AnaptysBio, Inc. (ANAB) Das Formular 144 weist den beabsichtigten Verkauf von 10,231 Stammaktien mit einem Gesamtmarktwert von $200,712.78 aus, der am oder um den 08/08/2025 眉ber Morgan Stanley Smith Barney an der NASDAQ ausgef眉hrt werden soll. Die Einreichung gibt an, dass diese Aktien am 08/08/2025 durch Aus眉bung einer Aktienoption mit Barzahlung erworben wurden. Die Mitteilung offenbart zudem fr眉here Verk盲ufe derselben Person, HOLLINGS C RENTON: 20,925 Aktien verkauft am 07/02/2025 f眉r $493,189.70 und 3,015 Aktien verkauft am 06/18/2025 f眉r $72,269.55. Der Unterzeichner erkl盲rt, dass keine nicht offengelegten wesentlichen nachteiligen Informationen vorliegen.
FAQ
What does the ANAB Form 144 disclose?
Who is the seller named in the filing for ANAB?
How were the 10,231 ANAB shares acquired?
Were there prior sales by the same person in the past three months?
On which exchange will the ANAB shares be sold?
